Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme activity that produces D-2-hydroxyglutarate. To model this disease, we conditionally expressed Idh1^R132H in the subventricular zone (SVZ) of the adult mouse brain. The mice developed hydrocephalus and grossly dilated lateral ventricles, with accumulation of 2-hydroxyglutarate and reduced -ketoglutarate. Stem and transit amplifying/progenitor cell populations were expanded, and proliferation increased. Cells expressing SVZ markers infiltrated surrounding brain regions. SVZ cells also gave rise to proliferative subventricular nodules. DNA methylation was globally increased, while hydroxymethylation was decreased...
<p>Gliomas are tumors of the central nervous system for which improvements in treatment are critical...
Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significan...
The high frequency of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in diffuse gliomas ind...
SummaryIsocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic e...
Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme a...
Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme a...
Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II-III glioma and secon...
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall survival of fi...
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall survival of fi...
The identification of the isocitrate dehydrogenase-1 mutation (IDH-1 R132H) in human gliomas has bee...
Mutation in isocitrate dehydrogenase 1 (IDH1R132H) occurs in various types of cancer, including low ...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Gliomas are the most frequent adult central nervous system (CNS) tumors. The 2016 published WHO CN...
Summary: Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II–III glioma ...
Somatic mutations in the catalytic domain of isocitrate dehydrogenase (IDH) 1/2 and accumulation of ...
<p>Gliomas are tumors of the central nervous system for which improvements in treatment are critical...
Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significan...
The high frequency of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in diffuse gliomas ind...
SummaryIsocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic e...
Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme a...
Isocitrate dehydrogenase 1 mutations drive human gliomagenesis, probably through neomorphic enzyme a...
Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II-III glioma and secon...
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall survival of fi...
Glioblastoma (GBM) is a devastating and incurable brain tumour, with a median overall survival of fi...
The identification of the isocitrate dehydrogenase-1 mutation (IDH-1 R132H) in human gliomas has bee...
Mutation in isocitrate dehydrogenase 1 (IDH1R132H) occurs in various types of cancer, including low ...
Objective: A high percentage of grade II and III gliomas have mutations in the gene encoding isocitr...
Gliomas are the most frequent adult central nervous system (CNS) tumors. The 2016 published WHO CN...
Summary: Isocitrate dehydrogenase 1 (IDH1) is the most commonly mutated gene in grade II–III glioma ...
Somatic mutations in the catalytic domain of isocitrate dehydrogenase (IDH) 1/2 and accumulation of ...
<p>Gliomas are tumors of the central nervous system for which improvements in treatment are critical...
Isocitrate dehydrogenase-1 (IDH1) R132 mutations occur in glioma, but their physiological significan...
The high frequency of mutations in the isocitrate dehydrogenase 1 (IDH1) gene in diffuse gliomas ind...